Real events, real consequences. Drug withdrawals, regulatory battles, blockbuster launches and industry-defining moments — explained plainly.
Six case studies are already planned — Thalidomide, Ranbaxy, Vioxx, COVID-19 vaccines, Lipitor's patent cliff, and Bayer-Monsanto. Subscribe to get them when they land.
Get notified →